David Tyronne Howton compensation by year
Solid Biosciences Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $513,422 |
| Bonus | $265,696 |
| Stock awards | $1,000,488 |
| Option awards | $796,621 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $12,600 |
| Total | $2,588,827 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Solid Biosciences Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-173642, and prior-year filings. Open the filing on EDGAR.
Solid Biosciences’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Alexander Cumbo | President, Chief Executive Officer and Director | $5,223,442 |
| David Tyronne Howton · this page | Chief Operating Officer and Secretary | $2,588,827 |
| Gabriel Brooks | Chief Medical Officer | $2,328,156 |
The full Solid Biosciences compensation record
free company briefThis page is one person within Solid Biosciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Solid Biosciences's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Solid Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat